| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/23/2010 | US20100240871 Galactose Alpha(1-3) Galactose Compositions |
| 09/23/2010 | US20100240870 Composite organic-inorganic nanoclusters |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240590 Peptides and related molecules that bind to tall-1 |
| 09/23/2010 | US20100240582 Peptides and related molecules that modulate nerve growth factor activity |
| 09/23/2010 | US20100240574 Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor |
| 09/23/2010 | US20100240146 Fluorescent protein particles |
| 09/23/2010 | US20100240145 Novel hemopoietin receptor protein, NR10 |
| 09/23/2010 | US20100240106 Mutant enzymes |
| 09/23/2010 | US20100240101 Parallel Proximity Ligation Event Analysis |
| 09/23/2010 | US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 09/23/2010 | US20100240066 Compounds and methods for modulating cadherin-mediated processes |
| 09/23/2010 | US20100240054 Identification and isolation of fetal cells and nucleic acid |
| 09/23/2010 | US20100240039 Fhl1 mutations associated with novel x-linked muscular myopathies |
| 09/23/2010 | US20100239649 Tumor Suppressor Factor |
| 09/23/2010 | US20100239633 Immunoglobulin constant region fc receptor binding agents |
| 09/23/2010 | US20100239615 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2010 | US20100239598 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 09/23/2010 | US20100239597 Anti-ADDL monoclonal antibody and use thereof |
| 09/23/2010 | US20100239594 Compositions and methods for production of immunoglobulins |
| 09/23/2010 | US20100239593 Rsv-specific binding molecules and means for producing them |
| 09/23/2010 | US20100239591 Monoclonal antibody for app |
| 09/23/2010 | US20100239590 Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease |
| 09/23/2010 | US20100239588 The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereof |
| 09/23/2010 | US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors |
| 09/23/2010 | US20100239586 Procalin polypeptides, antigens, and methods of use |
| 09/23/2010 | US20100239585 Antibodies Against Mammalian Metapneumovirus |
| 09/23/2010 | US20100239584 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x |
| 09/23/2010 | US20100239583 Antibodies against flagellin and uses thereof |
| 09/23/2010 | US20100239582 Dual Specificity Antibody Fusions |
| 09/23/2010 | US20100239581 Kidney disease targets and uses thereof |
| 09/23/2010 | US20100239580 Taci-immunoglobulin fusion proteins for treatment of optic neuritis |
| 09/23/2010 | US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders |
| 09/23/2010 | US20100239578 Modulation of sirp-alpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 09/23/2010 | US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma |
| 09/23/2010 | US20100239575 Anti-cd40 antibodies and uses thereof |
| 09/23/2010 | US20100239574 High potency recombinant antibodies and method for producing them |
| 09/23/2010 | US20100239573 METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Bb SPECIFIC ANTIBODIES |
| 09/23/2010 | US20100239572 Methods for treating and preventing gi syndrome and graft versus host disease |
| 09/23/2010 | US20100239571 CD30 Binding Agents and Uses Thereof |
| 09/23/2010 | US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof |
| 09/23/2010 | US20100239569 Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent |
| 09/23/2010 | US20100239564 Novel human growth factors |
| 09/23/2010 | US20100239545 Transfection with nucleic acid; insertion |
| 09/23/2010 | US20100239517 Novel conjugated proteins and peptides |
| 09/23/2010 | US20100239501 Gene sensitive to bone/joint disease and use thereof |
| 09/23/2010 | CA2851737A1 Alpha-4beta-7 heterodimer specific antagonist antibody |
| 09/23/2010 | CA2769276A1 Humanised antibodies with anti-tumour activity |
| 09/23/2010 | CA2755905A1 Optimized fc variants |
| 09/23/2010 | CA2755821A1 Human immunodeficiency virus (hiv) -neutralizing antibodies |
| 09/23/2010 | CA2755782A1 Biomarkers and uses thereof |
| 09/23/2010 | CA2755640A1 Multispecific anti-her antibodies |
| 09/23/2010 | CA2755336A1 Carrier immunoglobulins and uses thereof |
| 09/23/2010 | CA2755273A1 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 09/23/2010 | CA2754113A1 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 09/23/2010 | CA2752663A1 Reagents for the atherosclerotic coronary plaque and uses thereof |
| 09/23/2010 | CA2748889A1 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 09/22/2010 | EP2230335A2 Method to screen phage display libraries with different ligands |
| 09/22/2010 | EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/22/2010 | EP2230307A1 Neutrokine alpha |
| 09/22/2010 | EP2230300A1 Polypeptide having enhanced effector function |
| 09/22/2010 | EP2230299A1 Novel cytokine ZCYTOR17 ligand |
| 09/22/2010 | EP2230256A1 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 09/22/2010 | EP2230255A1 Feline pancreatic lipase |
| 09/22/2010 | EP2230254A2 Anti-IGFR1 antibody therapeutic combinations |
| 09/22/2010 | EP2230253A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 09/22/2010 | EP2230252A1 Augmentation of endothelial thromboresistance |
| 09/22/2010 | EP2230251A1 Antibodies specifically active in the coronary plaque and method for their identification |
| 09/22/2010 | EP2230250A1 Anti-hiv monoclonal antibody |
| 09/22/2010 | EP2230249A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 09/22/2010 | EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same |
| 09/22/2010 | EP2229410A2 Aglycosylated immunoglobulin mutants |
| 09/22/2010 | EP2229409A1 Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies |
| 09/22/2010 | EP2229405A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 09/22/2010 | EP1962094B1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 09/22/2010 | EP1639014B1 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 09/22/2010 | EP1133565B1 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/22/2010 | CN101842707A Immunoassay for quantification of an unstable antigen selected from BNP and proBNP |
| 09/22/2010 | CN101842490A Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 09/22/2010 | CN101842390A Antibodies against RAMP3 |
| 09/22/2010 | CN101842389A Anti-cd20 therapeutic compositions and methods |
| 09/22/2010 | CN101842388A Humanized antibodies against the beta-amyloyd peptide |
| 09/22/2010 | CN101842387A Dual specificity antibody fusions |
| 09/22/2010 | CN101842383A Novel plant virus designated tomato marchitez virus |
| 09/22/2010 | CN101842117A Anti-IGF-1R antibodies and uses thereof |
| 09/22/2010 | CN101842116A Compositions that bind multiple epitopes of IGF-1R |
| 09/22/2010 | CN101839918A Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof |
| 09/22/2010 | CN101838662A Prokaryotic expression vector of candida dihydroxyl acetone synthetase, building method thereof and application thereof |
| 09/22/2010 | CN101838660A Mycobacterium tuberculosis recombinant fusion protein and application thereof |
| 09/22/2010 | CN101838650A Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody |
| 09/22/2010 | CN101838328A Anti-vegf antibodies |
| 09/22/2010 | CN101838322A Malaria recombinant antigen, IgY immune body and malaria detection kit |
| 09/22/2010 | CN101838318A Anti-HIV-I polypeptide and coding sequence and use thereof |
| 09/22/2010 | CN101837124A Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 09/22/2010 | CN101148670B Preparation for breast cancer monoclonal antibody M4G3 single-chain antibody and DNA sequence thereof |
| 09/21/2010 | US7799905 T1R1 nucleic acid sequences and vectors containing same |
| 09/21/2010 | US7799902 Receptor coupling agents and compositions thereof |
| 09/21/2010 | US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein |
| 09/21/2010 | US7799900 humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases; treatment of B-cell associated diseases |
| 09/21/2010 | US7799899 Compositions and methods relating to STOP-1 |